Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Belgian COVID-19 Mortality, Excess Deaths, Number of Deaths per Million, and Infection Fatality Rates (9 March — 28 June 2020)

View ORCID ProfileGeert Molenberghs, View ORCID ProfileChristel Faes, Johan Verbeeck, Patrick Deboosere, Steven Abrams, Lander Willem, View ORCID ProfileJan Aerts, View ORCID ProfileHeidi Theeten, View ORCID ProfileBrecht Devleesschauwer, View ORCID ProfileNatalia Bustos Sierra, View ORCID ProfileFrançoise Renard, View ORCID ProfileSereina Herzog, View ORCID ProfilePatrick Lusyne, View ORCID ProfileJohan Van der Heyden, View ORCID ProfileHerman Van Oyen, View ORCID ProfilePierre Van Damme, View ORCID ProfileNiel Hens
doi: https://doi.org/10.1101/2020.06.20.20136234
Geert Molenberghs
1Data Science Institute, I-BioStat, Universiteit Hasselt, BE-3500 Hasselt. Belgium
2I-BioStat, KU Leuven, BE-3000 Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Geert Molenberghs
  • For correspondence: geert.molenberghs@uhasselt.be
Christel Faes
1Data Science Institute, I-BioStat, Universiteit Hasselt, BE-3500 Hasselt. Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christel Faes
Johan Verbeeck
1Data Science Institute, I-BioStat, Universiteit Hasselt, BE-3500 Hasselt. Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Deboosere
3Interface Demography (ID), Department of Sociology, Vrije Universiteit Brussel, BE-1050 Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Abrams
1Data Science Institute, I-BioStat, Universiteit Hasselt, BE-3500 Hasselt. Belgium
4Global Health Institute (GHI), Family Medicine and Population Health, University of Antwerp, BE-2000 Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lander Willem
5Centre for Health Economics Research and Modelling of Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO). University of Antwerp, BE-2000 Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Aerts
1Data Science Institute, I-BioStat, Universiteit Hasselt, BE-3500 Hasselt. Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jan Aerts
Heidi Theeten
6Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, BE-2000 Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Heidi Theeten
Brecht Devleesschauwer
7Department of Epidemiology and Public Health, Sciensano, BE-1050 Brussels, Belgium
8Department of Veterinary Public Health and Food Safety, Ghent University, BE-9820 Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brecht Devleesschauwer
Natalia Bustos Sierra
7Department of Epidemiology and Public Health, Sciensano, BE-1050 Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Natalia Bustos Sierra
Françoise Renard
7Department of Epidemiology and Public Health, Sciensano, BE-1050 Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Françoise Renard
Sereina Herzog
5Centre for Health Economics Research and Modelling of Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO). University of Antwerp, BE-2000 Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sereina Herzog
Patrick Lusyne
9Statistics Belgium, BE-1000 Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patrick Lusyne
Johan Van der Heyden
7Department of Epidemiology and Public Health, Sciensano, BE-1050 Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Johan Van der Heyden
Herman Van Oyen
7Department of Epidemiology and Public Health, Sciensano, BE-1050 Brussels, Belgium
10Department of Public Health and Primary Care, Ghent University, BE-9000, Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Herman Van Oyen
Pierre Van Damme
6Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, BE-2000 Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pierre Van Damme
Niel Hens
1Data Science Institute, I-BioStat, Universiteit Hasselt, BE-3500 Hasselt. Belgium
5Centre for Health Economics Research and Modelling of Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO). University of Antwerp, BE-2000 Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Niel Hens
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background COVID-19 mortality and its relation to excess deaths, the number of Deaths Per Million (DPM), Infection Fatality Rates (IFRs) and Case Fatality Rates (CFRs) are constantly being reported and compared for a large number of countries globally. These measures may appear objective, however they should be interpreted with the necessary care.

Objective Scrutiny of COVID-19 mortality in Belgium over the period 9 March – 28 June 2020 (Weeks 11–26), using the relation between COVID-19 mortality and excess death rates, the number of deaths per million, and infection fatality rates.

Methods The relation between COVID-19 reported mortality and excess death rates is evaluated by comparing publicly available COVID-19 mortality (2020) and the difference of observed and predicted overall mortality. Predictions are based on weekly averages of historical overall mortality data in Belgium (2009–2019). Deaths per million are evaluated using demographic data of the Belgian population (2020). The infection fatality rate is estimated using a delay distribution between infection and death. The number of infections in Belgium is estimated by a stochastic compartmental model, which uses hospitalisation data, serial serological survey data, and COVID-19 mortality data (2020) for calibration.

Results In Belgium, 9621 COVID-19 related deaths are reported between 9 March and 28 June 2020, which is close to the excess mortality estimated by weekly averages of historical mortality data (8985 deaths). This translates to 837 DPM and an IFR of 1.5% in the general population in Belgium. Both DPM and IFR increase with age and are substantially larger in the nursing home population.

Conclusion Belgium has virtually no discrepancy between COVID-19 reported mortality and excess mortality. Due to this close agreement it is useful to consider the DPM and IFR, which are both age, sex, and nursing home population dependent. Data comparison of COVID-19 mortality between countries should rather be based on excess mortality than reported mortality.

Competing Interest Statement

All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that (1) PVD reports research grants from GSK Biologicals, Pfizer, SANOFI, Merck, Themis, Osivax, J&J and Abbott, grants from The Bill & Melinda Gates Foundation, PATH, Flemish Government, and European Union, outside the submitted work; (2) GM acts as advisor and member of International Data Monitoring Committees for several biopharmaceutical clinical trials, including for a COVID-19 vaccination trial of J and J; he receives research funding from GSK; (3) none of the other authors has anything to disclose.

Funding Statement

This project has received funding from the European Union's Horizon 2020 Research and Innovation Programma - Project EpiPose (No 101003688). The sero-prevalence study of which the results are used in this manuscript has been sponsored by the University of Antwerp's Research Fund.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Manuscript thoroughly revised to address comments by reviewers of Eurosurveillance. Period over which the study runs expanded to 9 March - 28 June 2020.

Data Availability

Data can be obtained from the authors upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 08, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Belgian COVID-19 Mortality, Excess Deaths, Number of Deaths per Million, and Infection Fatality Rates (9 March — 28 June 2020)
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Belgian COVID-19 Mortality, Excess Deaths, Number of Deaths per Million, and Infection Fatality Rates (9 March — 28 June 2020)
Geert Molenberghs, Christel Faes, Johan Verbeeck, Patrick Deboosere, Steven Abrams, Lander Willem, Jan Aerts, Heidi Theeten, Brecht Devleesschauwer, Natalia Bustos Sierra, Françoise Renard, Sereina Herzog, Patrick Lusyne, Johan Van der Heyden, Herman Van Oyen, Pierre Van Damme, Niel Hens
medRxiv 2020.06.20.20136234; doi: https://doi.org/10.1101/2020.06.20.20136234
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Belgian COVID-19 Mortality, Excess Deaths, Number of Deaths per Million, and Infection Fatality Rates (9 March — 28 June 2020)
Geert Molenberghs, Christel Faes, Johan Verbeeck, Patrick Deboosere, Steven Abrams, Lander Willem, Jan Aerts, Heidi Theeten, Brecht Devleesschauwer, Natalia Bustos Sierra, Françoise Renard, Sereina Herzog, Patrick Lusyne, Johan Van der Heyden, Herman Van Oyen, Pierre Van Damme, Niel Hens
medRxiv 2020.06.20.20136234; doi: https://doi.org/10.1101/2020.06.20.20136234

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1747)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (653)
  • Epidemiology (10780)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2933)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1918)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12496)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (321)
  • Neurology (2780)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (554)
  • Occupational and Environmental Health (597)
  • Oncology (1454)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (379)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2630)
  • Public and Global Health (5338)
  • Radiology and Imaging (1002)
  • Rehabilitation Medicine and Physical Therapy (594)
  • Respiratory Medicine (722)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)